Results 161 to 170 of about 8,661 (182)

Nirmatrelvir+ritonavir

Reactions Weekly
  +5 more sources

Nirmatrelvir+ritonavir/tozinameran

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir+ritonavir/tozinameran

Reactions Weekly, 2022
openaire   +1 more source

Nirmatrelvir-Ritonavir (Paxlovid)

Canadian Journal of Health Technologies
CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform non-binding recommendations that help guide the reimbursement decisions of Canada's federal, provincial, and territorial governments, with the ...
openaire   +1 more source

Paxlovid (nirmatrelvir/ritonavir).

WMJ : official publication of the State Medical Society of Wisconsin, 2022
Kristin, Busse, Abir T, El-Alfy
openaire   +1 more source

Ciclosporin/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Molnupiravir/nirmatrelvir+ritonavir

Reactions Weekly, 2023
  +4 more sources

Immunosuppressants/nirmatrelvir+ritonavir

Reactions Weekly, 2022
openaire   +1 more source

Nifedipine/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir and ritonavir

Clinical Therapeutics
openaire   +2 more sources